about
A place to call home: study protocol for a longitudinal, mixed methods evaluation of two housing first adaptations in Sydney, AustraliaMental and behavioral disorders due to substance abuse and perinatal outcomes: a study based on linked population data in New South Wales, AustraliaUsing population data to examine the prevalence and correlates of neonatal abstinence syndrome.Fetal alcohol spectrum disorder: development of consensus referral criteria for specialist diagnostic assessment in AustraliaOffending, custody and opioid substitution therapy treatment utilisation among opioid-dependent people in contact with the criminal justice system: comparison of Indigenous and non-Indigenous AustraliansHealth professionals' perceptions about the adoption of existing guidelines for the diagnosis of fetal alcohol spectrum disorders in AustraliaCounting fetal alcohol spectrum disorder in Australia: the evidence and the challenges.A modified Delphi study of screening for fetal alcohol spectrum disorders in AustraliaThe increased trend in mothers' hospital admissions for psychiatric disorders in the first year after birth between 2001 and 2010 in New South Wales, AustraliaHospital admissions for alcohol use disorders before, during, and after pregnancy: a study based on linked population data in new South Wales, Australia.Recommendations from a consensus development workshop on the diagnosis of fetal alcohol spectrum disorders in AustraliaThe impact of opioid substitution therapy on mortality post-release from prison: retrospective data linkage study.The importance of blood-borne viruses in elevated cancer risk among opioid-dependent people: a population-based cohort study.Consensus diagnostic criteria for fetal alcohol spectrum disorders in Australia: a modified Delphi study.How does the use of multiple needles/syringes per injecting episode impact on the measurement of individual level needle and syringe program coverage?Involving consumers and the community in the development of a diagnostic instrument for fetal alcohol spectrum disorders in Australia.Opioid substitution therapy as a strategy to reduce deaths in prison: retrospective cohort study.Monitoring drug markets in the Internet age and the evolution of drug monitoring systems in Australia.Prematurity reduces the severity and need for treatment of neonatal abstinence syndrome.Opioid substitution therapy is associated with increased detection of hepatitis C virus infection: a 15-year observational cohort study.Mortality among clients of a state-wide opioid pharmacotherapy program over 20 years: risk factors and lives saved.Evaluating health outcomes of criminal justice populations using record linkage: the importance of aliases.Trends in reports of driving following illicit drug consumption among regular drug users in Australia, 2007-2013: Has random roadside drug testing had a deterrent effect?New psychoactive substances: Purchasing and supply patterns in Australia.I like the old stuff better than the new stuff? Subjective experiences of new psychoactive substances.Alcohol consumption by breastfeeding mothers: Frequency, correlates and infant outcomes.The recovery of online drug markets following law enforcement and other disruptions.Maternal Bonding through Pregnancy and Postnatal: Findings from an Australian Longitudinal Study.Weight in the First Year of Life: Associations with Maternal Prepregnancy Body Mass Index and Gestational Weight Gain-Findings from a Longitudinal Pregnancy Cohort.Motivations for new psychoactive substance use among regular psychostimulant users in Australia.Neonatal Abstinence Syndrome and High School Performance.Trajectories of heroin use: 10-11-year findings from the Australian Treatment Outcome Study.Most recent risky drinking session with Australian teenagers.Who sells what? Country specific differences in substance availability on the Agora cryptomarket.Evaluating the Impact of Hospital Based Drug and Alcohol Consultation Liaison Services.Emerging psychoactive substance use among regular ecstasy users in Australia.Crystalline methamphetamine use and methamphetamine-related harms in Australia.Increasing cancer mortality among opioid-dependent persons in Australia: a new public health challenge for a disadvantaged population.Syringe Stockpiling by Persons Who Inject Drugs: An Evaluation of Current Measures for Needle and Syringe Program Coverage.Drug testing in sport: the attitudes and experiences of elite athletes.
P50
Q30638343-ABA8BC19-A118-4875-8288-20B50C87963AQ30818398-105140E3-2834-40B7-99C7-42580517166DQ31121884-A25B7872-5EF8-4E40-BD5F-AED214868CC0Q34009326-CFA1A875-6213-4BD5-9F8E-7436847E6A64Q34207684-A5C72AE4-BBE1-446B-BB4F-EA1439BFB4DBQ34303879-4C6A4A18-2BD5-4A9D-ADE3-1BB274E58741Q34341201-0E6FF1C8-A346-4729-839D-B65D4286E5FFQ34561442-7E5AF6BE-FBB0-44F9-BC82-24FED0C8908DQ34665794-012C7D03-F457-448C-9382-E334A08058BDQ34771279-29C91BF3-C45C-496F-A7B9-5C2536F591ADQ35003760-59F02AA8-C4A6-4CD7-A709-B5FF8F077D99Q35115444-133C4339-98DC-4E62-B784-C05431DB5322Q36370353-725AC236-4471-4ECB-A51B-4D6327011A8AQ36370387-C159A8AD-5056-4509-80FC-56853A129A4BQ36414152-B478C408-7239-43CC-86FC-90FD2D4F7AFFQ37070944-27F3ED6A-0961-4289-A5AF-DA6ACB3E4750Q37704453-15C36068-3A42-4295-8C4D-2D08C27E353BQ38191503-091BB4BA-071F-40F0-A4AC-04E1E1DA4D30Q38331874-43EAE084-E6E3-4715-AB0D-4784F0D3096EQ38416854-29773C59-DE70-4E96-98B8-D43036345554Q38449652-A8CDBAC7-9E4E-4188-9901-1EBCF83EB8F0Q38493486-E200A2B7-B6A5-4BBB-9E14-FC490A3A9AF4Q38773428-3FB54AD7-4287-4CFF-9D5F-545BE16A2594Q38778830-2AC221BF-E9F6-49B9-9707-D24AE6D517BEQ38784633-70AC5373-8615-4F64-A176-44D590E9509EQ38906637-41CC69B6-04D1-4E7E-BF00-3F38435BA754Q38929843-BB70AC0F-3280-42CD-B47B-5D2EE4DE8C4BQ38955065-1ABBE5BA-0FDD-4F9D-AFA8-2040D88A67FEQ38971603-8A0284AB-0908-498B-82D2-3F4C049117E6Q38978828-AC0764FD-679A-42D8-A389-7089E54A7F54Q39017679-BF4C40FE-FB93-492C-8FD5-32C38D149E70Q39035991-928081C2-FF69-4DAD-A28C-BF8954629E78Q39256013-4AD89B1F-E26C-418D-B3BE-C340057B572CQ39494202-C1850109-4158-41EC-84ED-607B5514F057Q39588120-B0822B08-405E-4574-8009-016C580A0318Q39668901-BBF0C1A0-67A6-4999-B50C-B51276E9A7FFQ39693051-4F265698-19AE-4A10-931C-C6DAF159CBAFQ39744271-F7EC4234-8ADE-47B5-9661-6343150FD04AQ39860271-54F11747-C281-41C3-B47F-F259E5BF674BQ39909358-A596ECD7-FDFD-4B38-A012-2409A7208E91
P50
description
hulumtuese
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Lucinda Burns
@ast
Lucinda Burns
@en
Lucinda Burns
@es
Lucinda Burns
@nl
Lucinda Burns
@sl
type
label
Lucinda Burns
@ast
Lucinda Burns
@en
Lucinda Burns
@es
Lucinda Burns
@nl
Lucinda Burns
@sl
altLabel
Burns L
@en
Lucinda Burns
@en
Lucy Burns
@en
prefLabel
Lucinda Burns
@ast
Lucinda Burns
@en
Lucinda Burns
@es
Lucinda Burns
@nl
Lucinda Burns
@sl
P1053
M-7882-2013
P106
P1153
8570873300
P21
P31
P3829
P496
0000-0003-3178-8091